[Congressional Record Volume 168, Number 157 (Wednesday, September 28, 2022)]
[Senate]
[Pages S5395-S5396]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5929. Mr. HAGERTY submitted an amendment intended to be proposed 
to amendment SA 5499 submitted by Mr. Reed (for himself and Mr. Inhofe) 
and intended to be proposed to the bill H.R. 7900, to authorize 
appropriations for fiscal year 2023 for military activities of the 
Department of Defense, for military construction, and for defense 
activities of the Department of Energy, to prescribe military personnel 
strengths for such fiscal year, and for other purposes; which was 
ordered to lie on the table; as follows:
        At the end of subtitle D of title XII, add the following:

     SEC. 1254. REPORTS ON PRODUCTION, INTERNATIONAL TRANSPORT, 
                   AND SEIZURE OF CERTAIN ILLICIT DRUGS.

       (a) Findings.--Congress finds the following:
       (1) In January 2020, the Drug Enforcement Agency named 
     China as the primary source

[[Page S5396]]

     of United States-bound, illicit, fentanyl-related substances.
       (2) Although China instituted domestic controls in 2018 and 
     2019 on the production and exportation of fentanyl, some of 
     its variants, and two precursors known as NPP and 4-ANPP, and 
     the United Nations Commission on Narcotic Drugs recently 
     voted unanimously in favor of controlling 4-AP and two other 
     precursors, China has not yet expanded its class scheduling 
     to include many fentanyl precursors, such as 4-AP, which 
     continue to be trafficked to second countries in which they 
     are used in the final production of United States-bound 
     fentanyl and other synthetic opioids.
       (3) According to the Commission on Combating Synthetic 
     Opioid Trafficking Final Report, which was published in 
     February 2022, illicit fentanyl and related analogues 
     entering the United States are now primarily trafficked 
     across the southern border from Mexico, where drug cartels 
     use precursors from China to manufacture these deadly 
     substances.
       (4) The Joint Interagency Task Force West, which is part of 
     United States Indo-Pacific Command, uses military and law 
     enforcement capabilities to combat drug-related transnational 
     crime in the Asia-Pacific Region, including by supporting law 
     enforcement in efforts to reduce the illicit flow of drugs 
     and precursors originating in Asia and intended for markets 
     in the United States.
       (5) From June 2020 through May 2021, more than 100,000 
     Americans died from drug overdoses, roughly two-thirds of 
     which involved synthetic opioids, such as fentanyl and 
     related analogues.
       (b) Definitions.--In this section:
       (1) Appropriate committees of congress.--The term 
     ``appropriate committees of Congress'' means--
       (A) the Committee on Armed Services of the Senate;
       (B) the Committee on the Judiciary of the Senate;
       (C) the Committee on Foreign Relations of the Senate;
       (D) the Committee on Armed Services of the House of 
     Representatives;
       (E) the Committee on the Judiciary of the House of 
     Representatives; and
       (F) the Committee on Foreign Affairs of the House of 
     Representatives.
       (2) China.--The term ``China'' means the People's Republic 
     of China.
       (3) Precursors.--The term ``precursors'' means chemicals 
     used in the illicit production of fentanyl and related 
     synthetic opioid variants.
       (c) Report on China's Scheduling of Fentanyl and Synthetic 
     Opioid Precursors and Steps to Combat Fentanyl Production and 
     Trafficking in China.--Not later than 180 days after the date 
     of the enactment of this Act, the Secretary of Defense, 
     acting through the Director of the Joint Interagency Task 
     Force West and in consultation with the Secretary of State 
     and the Attorney General, shall submit to the appropriate 
     committees of Congress an unclassified written report, with a 
     classified annex, that includes--
       (1) a description of United States Government efforts to 
     secure implementation by the Chinese Government of 
     international narcotics controls regarding unregulated 
     fentanyl precursors, such as 4-AP; and
       (2) a plan for future steps the United States Government 
     will take to combat illicit fentanyl production and 
     trafficking originating in China.
       (d) Annual Report on Drug Seizures.--Not later than 6 
     months after the date of the enactment of this Act, and 
     annually thereafter, the Secretary of Defense, acting through 
     the Director of the Joint Interagency Task Force West and in 
     coordination with the Drug Enforcement Agency, the Office of 
     National Drug Control Policy, U.S. Customs and Border 
     Protection, the Department of Homeland Security, the 
     Department of Justice, the Coast Guard, the Centers for 
     Disease Control and Prevention, the Office of the United 
     States Trade Representative, the Office of the Director of 
     National Intelligence, the Central Intelligence Agency, the 
     Department of State, the United States Postal Service, and 
     any other relevant agency, shall submit a report to the 
     appropriate committees of Congress that describes--
       (1) with respect to illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors that originated in the Asia-
     Pacific region and have been seized at the United States 
     borders and ports of entry--
       (A) the source countries from which such drugs originated 
     and the third party countries through which such drugs 
     traveled;
       (B) the methods used for transporting such drugs from the 
     Asia-Pacific region to the United States borders and ports of 
     entry;
       (C) the amounts of illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors; and
       (D) the lethality of the amounts of illicit fentanyl, 
     fentanyl analogues, synthetic opioids, the precursors for 
     illicit fentanyl, fentanyl analogues, or synthetic opioids, 
     methamphetamine, or methamphetamine precursors seized;
       (2) with respect to illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors that originated in the Asia-
     Pacific region and have been seized within the United 
     States--
       (A) the source countries from which such drugs originated 
     and the third party countries through which such drugs 
     traveled;
       (B) the methods used for transporting such drugs from the 
     Asia-Pacific region to the United States borders and ports of 
     entry;
       (C) the amounts of illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors seized; and
       (D) the lethality of the amounts of illicit fentanyl, 
     fentanyl analogues, synthetic opioids, the precursors for 
     illicit fentanyl, fentanyl analogues, or synthetic opioids, 
     methamphetamine, or methamphetamine precursors seized; and
       (3) the activities conducted by Chinese entities and 
     nationals in furtherance of illicit fentanyl production in 
     Mexico for drug trafficking purposes.
                                 ______